Location History:
- Pottstown, PA (US) (1992 - 1996)
- Belmont, CA (US) (1994 - 2008)
Company Filing History:
Years Active: 1992-2008
Title: The Innovations of Kenneth C Cundy
Introduction
Kenneth C Cundy is a notable inventor based in Belmont, California. He has made significant contributions to the field of nucleotide analogs, holding a total of nine patents. His work has advanced the understanding and application of nucleotide analogs in various scientific domains.
Latest Patents
Cundy's latest patents focus on nucleotide analogs characterized by the presence of an amidate linked amino acid or an ester linked group. These groups are bonded to the phosphorus atom of phosphonate nucleotide analogs. The analogs comprise a phosphoamidate or ester bond that is hydrolyzed in vivo to yield a corresponding phosphonate nucleotide analog. Methods and intermediates for their synthesis and use are also described in his patents.
Career Highlights
Throughout his career, Kenneth C Cundy has worked with prominent companies such as Gilead Sciences, Inc. and Sterling Drug Inc. His experience in these organizations has contributed to his expertise in the field of nucleotide research and development.
Collaborations
Cundy has collaborated with notable colleagues, including Murty N Arimilli and Joseph P Dougherty. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
Kenneth C Cundy's innovative work in nucleotide analogs has positioned him as a significant figure in the field of biotechnology. His contributions continue to influence research and applications in this vital area of science.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.